Table 1.
No. | Compound Structure | SARS CoV-2 3CLpro IC50 (µM) |
SARS-CoV-2 EC50 (µM) a |
---|---|---|---|
1 | 0.36 | >100 | |
2 | 0.67 | >100 | |
3 | 0.16 | >100 | |
4 | 0.81 | >100 | |
5 | 5.32 | 30.2 |
a Compounds 3 and 5 exhibited antiviral EC50 values of 2.8 and 2.4 μm, respectively.
No. | Compound Structure | SARS CoV-2 3CLpro IC50 (µM) |
SARS-CoV-2 EC50 (µM) a |
---|---|---|---|
1 | 0.36 | >100 | |
2 | 0.67 | >100 | |
3 | 0.16 | >100 | |
4 | 0.81 | >100 | |
5 | 5.32 | 30.2 |
a Compounds 3 and 5 exhibited antiviral EC50 values of 2.8 and 2.4 μm, respectively.